San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
Source: Press Release
San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination